US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

According to IMARC Group’s latest report, titled US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the market reached a value of US$ 83.2 Billion in 2021. A generic drug consists of similar chemical makeup, active ingredient, and therapeutic effect as branded drugs. The manufacturing costs of generic medications are comparatively cheaper and they do not require extensive research and testing. They also exhibit equivalent performance, application, strength, route of administration, quality, and dosage to their branded counterparts. Generic drugs are usually manufactured post expiration of the patent of the branded drugs.

Request for a PDF sample of this report:

The growing prevalence of several cardiovascular diseases and the steadily rising geriatric population are key factors driving the generic drug market across the US. In line with this, the surging healthcare expenditure has significantly boosted the demand for generic drugs, thus supporting the market growth. Moreover, the escalating number of clinical trials and rapid patent expiry of branded drugs are factors accelerating the market growth. Furthermore, the Federal Government of the United States (US Federal Government) is introducing several programs to offer an incentive to pharmacists and physicians to promote generic drug substitution across the nation, which is creating a positive outlook for the market. Looking forward, IMARC Group expects the US generic drug market to reach US$ 105.7 Billion by 2027, exhibiting a CAGR of 3.9% during 2022-2027.

Checkout Now:

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

  • Teva
  • Mylan
  • Actavis (Teva)
  • Sandoz (Novartis)
  • Sun Pharma
  • Par Pharmaceuticals (Endo Pharmaceuticals)
  • Lupin Pharmaceuticals
  • Dr Reddy’s
  • Hospira (Pfizer)

Key Highlights of the Market Segmentation:

Breakup by Segment:

  • Unbranded
  • Branded

Breakup by Therapy Area:

  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

Breakup by Drug Delivery:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies

Ask Analyst for Customization and Explore full report with TOC & List of Figures

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Trauma Care Centers Market:

Laboratory Proficiency Testing Market:

Extracorporeal Membrane Oxygenation Machine Market:

Medical Tapes and Bandages Market:

Oligonucleotide Synthesis Market:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming


Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *

18 − two =

One reply on “US Generic Drug Market”

  • July 1, 2022 at 6:36 am

    I’m not that much of a online reader to be honest but your blogs really
    nice, keep it up! I’ll go ahead and bookmark your website to come back later on.
    All the best aid for ukraine